HK1137341A1 - Association of a sinus node if current inhibitor and a beta blocker - Google Patents

Association of a sinus node if current inhibitor and a beta blocker

Info

Publication number
HK1137341A1
HK1137341A1 HK10101056.7A HK10101056A HK1137341A1 HK 1137341 A1 HK1137341 A1 HK 1137341A1 HK 10101056 A HK10101056 A HK 10101056A HK 1137341 A1 HK1137341 A1 HK 1137341A1
Authority
HK
Hong Kong
Prior art keywords
association
beta blocker
sinus node
current inhibitor
inhibitor
Prior art date
Application number
HK10101056.7A
Other languages
English (en)
Inventor
Pigeonniere Guy Lerebours
Jean-Henri Calvet
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39666229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1137341(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1137341A1 publication Critical patent/HK1137341A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK10101056.7A 2008-02-14 2010-01-29 Association of a sinus node if current inhibitor and a beta blocker HK1137341A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0800800A FR2927538B1 (fr) 2008-02-14 2008-02-14 Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.

Publications (1)

Publication Number Publication Date
HK1137341A1 true HK1137341A1 (en) 2010-07-30

Family

ID=39666229

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10101056.7A HK1137341A1 (en) 2008-02-14 2010-01-29 Association of a sinus node if current inhibitor and a beta blocker

Country Status (38)

Country Link
US (1) US8217030B2 (xx)
EP (2) EP2409694A1 (xx)
JP (2) JP2009191069A (xx)
KR (1) KR101078133B1 (xx)
CN (1) CN101507726B (xx)
AP (1) AP2010005366A0 (xx)
AR (1) AR070416A1 (xx)
AU (1) AU2009200393B2 (xx)
BR (1) BRPI0900470A2 (xx)
CA (1) CA2654210C (xx)
CO (1) CO6290712A2 (xx)
CR (1) CR11628A (xx)
CU (1) CU24007B1 (xx)
CY (1) CY1114113T1 (xx)
DK (1) DK2090303T3 (xx)
EA (1) EA200900137A1 (xx)
EC (1) ECSP10010402A (xx)
ES (1) ES2421893T3 (xx)
FR (1) FR2927538B1 (xx)
GE (1) GEP20115261B (xx)
HK (1) HK1137341A1 (xx)
HN (1) HN2010001608A (xx)
HR (1) HRP20130617T1 (xx)
IL (1) IL207386A0 (xx)
MA (1) MA31132B1 (xx)
ME (1) ME01014B (xx)
MX (1) MX2009001590A (xx)
MY (1) MY149122A (xx)
NI (1) NI201000139A (xx)
NZ (1) NZ574843A (xx)
PL (1) PL2090303T3 (xx)
PT (1) PT2090303E (xx)
RS (1) RS52834B (xx)
SG (1) SG155130A1 (xx)
SI (1) SI2090303T1 (xx)
UA (1) UA99817C2 (xx)
WO (1) WO2009115669A1 (xx)
ZA (1) ZA200900894B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
US9674435B1 (en) * 2016-07-06 2017-06-06 Lawrence Maxwell Monari Virtual reality platforms for capturing content for virtual reality displays
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503510A (ja) * 1989-11-21 1993-06-10 セプラカー・インコーポレーテツド 光学的に純粋な（ｓ）―アテノロールを含む組成物と方法
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
EP1426051B1 (en) * 2001-09-11 2008-07-16 Asahi Kasei Pharma Corporation Medicinal composition for prevention of or treatment for cerebrovascular disorder
PT1362590E (pt) 2002-07-25 2004-05-31 Boehringer Ingelheim Pharma Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
CN101095682A (zh) * 2007-07-23 2008-01-02 北京本草天源药物研究院 一种伊伐布雷定或其药用盐的口服制剂

Also Published As

Publication number Publication date
CN101507726A (zh) 2009-08-19
NZ574843A (en) 2011-07-29
ZA200900894B (en) 2009-12-30
US20090209515A1 (en) 2009-08-20
CY1114113T1 (el) 2016-07-27
CN101507726B (zh) 2012-03-28
IL207386A0 (en) 2010-12-30
KR20090088328A (ko) 2009-08-19
SG155130A1 (en) 2009-09-30
NI201000139A (es) 2011-01-10
HRP20130617T1 (xx) 2013-07-31
RS52834B (en) 2013-10-31
GEP20115261B (en) 2011-08-10
US8217030B2 (en) 2012-07-10
ES2421893T3 (es) 2013-09-06
FR2927538B1 (fr) 2010-02-19
CU24007B1 (es) 2014-06-27
FR2927538A1 (fr) 2009-08-21
AU2009200393A1 (en) 2009-09-03
CA2654210A1 (fr) 2009-08-14
MX2009001590A (es) 2009-08-24
ME01014B (me) 2012-10-20
MA31132B1 (fr) 2010-02-01
HN2010001608A (es) 2013-10-07
CA2654210C (fr) 2013-06-25
CU20100162A7 (es) 2011-10-31
UA99817C2 (ru) 2012-10-10
EP2090303A1 (fr) 2009-08-19
JP2012211179A (ja) 2012-11-01
SI2090303T1 (en) 2013-08-30
DK2090303T3 (da) 2013-07-29
BRPI0900470A2 (pt) 2009-09-29
EP2090303B1 (fr) 2013-05-01
MY149122A (en) 2013-07-15
PT2090303E (pt) 2013-05-31
AR070416A1 (es) 2010-04-07
AU2009200393B2 (en) 2013-11-07
PL2090303T3 (pl) 2013-07-31
ECSP10010402A (es) 2010-09-30
AP2010005366A0 (en) 2010-08-31
CO6290712A2 (es) 2011-06-20
EP2409694A1 (fr) 2012-01-25
KR101078133B1 (ko) 2011-10-28
EA200900137A1 (ru) 2009-10-30
WO2009115669A1 (fr) 2009-09-24
JP2009191069A (ja) 2009-08-27
CR11628A (es) 2010-11-22

Similar Documents

Publication Publication Date Title
HK1243713A1 (zh) 一種化合物的固體形式及其使用方法
HK1186180A1 (en) Beta lactamase inhibitors
EP2321846A4 (en) ELECTROSTATIC FODDER ASSEMBLY
HUE050786T2 (hu) Fibrózis inhibitor
IL209741A0 (en) Anti-inflammatory agents
GB0723875D0 (en) Wound management
EP2407476A4 (en) STEROID COMPOUND
EP2254576A4 (en) ABLATENT AGENTS OF THE ANDROGEN RECEPTOR
GB2466042B (en) Voltage reduction
IL207386A0 (en) Association of a sinus node if current inhibitor and a beta blocker
HK1202320A1 (en) Tilting-bowl toilet
HK1156569A1 (en) Core drill
TWI349069B (en) Curtain reel structure
HK1139575A1 (en) Outer space toilet
TWI373197B (en) Voltage converter
TWM347748U (en) Core structure
EP2227260A4 (en) NEW ABSORBENT SOUL
GB0710161D0 (en) Toilet brush
GB0816439D0 (en) First stage toilet
PL383211A1 (pl) Nowy związek oraz jego zastosowania
PL386302A1 (pl) Nowa pochodna izotiazolopirydyny
PL386905A1 (pl) Przekładnik napięciowy
PL385042A1 (pl) Przekładnik napięciowy
PL385043A1 (pl) Przekładnik napięciowy
GB0819546D0 (en) Toilet brush